AVIR -Atea Pharma’s Covid treatment fails to meet study goal
Oct 19, 2021 14:01:27 GMT
icemandios likes this
Post by c2crusher on Oct 19, 2021 14:01:27 GMT
Atea Pharma’s Covid treatment fails to meet study goal, shares plunge
www.cnbc.com/2021/10/19/atea-pharmas-covid-treatment-fails-to-meet-study-goal-shares-plunge.html
Atea Pharmaceuticals is developing the oral drug, AT-527, in partnership with Roche and both the companies are collaborating on multiple studies of the drug for the treatment of Covid-19.
In the mid-stage study, AT-527 did not show a clear reduction in SARS-CoV-2 viral load in the overall population of patients with mild or moderate Covid-19 compared to placebo.
www.tradingview.com/x/8yqysOwz/
www.cnbc.com/2021/10/19/atea-pharmas-covid-treatment-fails-to-meet-study-goal-shares-plunge.html
Atea Pharmaceuticals is developing the oral drug, AT-527, in partnership with Roche and both the companies are collaborating on multiple studies of the drug for the treatment of Covid-19.
In the mid-stage study, AT-527 did not show a clear reduction in SARS-CoV-2 viral load in the overall population of patients with mild or moderate Covid-19 compared to placebo.
www.tradingview.com/x/8yqysOwz/